Anti-beta Amyloid 抗体 [mOC23] - Conformation-Specific
Anti-beta Amyloid antibody [mOC23] - Conformation-Specific
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- Recombinant
- 詳細を見る
4
(1 Review)
|
(3 Publications)
Rabbit Recombinant Monoclonal Amyloid-beta precursor protein antibody. Suitable for IHC-P, Dot and reacts with Human, Synthetic peptide samples. Cited in 3 publications.
別名を表示する
A4, AD1, APP, Amyloid-beta precursor protein, ABPP, APPI, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid precursor protein, Amyloid-beta (A4) precursor protein, Amyloid-beta A4 protein, Cerebral vascular amyloid peptide, PreA4, Protease nexin-II, CVAP, PN-II
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-beta Amyloid antibody [mOC23] - Conformation-Specific (AB205340)
IHC image of beta Amyloid staining in Human Brain Alzheimer formalin fixed paraffin embedded tissue section*, performed on a Leica Bond™ system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab205340, 0.1μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre
- Dot
Supplier Data
Dot Blot - Anti-beta Amyloid antibody [mOC23] - Conformation-Specific (AB205340)
Dot blot analysis of beta Amyloid labeled with ab205340 at 1/6000 dilution.
Lane 1 : beta Amyloid (Aβ) 1-40;
Lane 2 : beta Amyloid (Aβ) 1-42.
Goat Anti-Rabbit IgG (H+L) Peroxidase conjugated (ab97051) at 1/30000 was used as secondary antibody.
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 30 seconds.
Note : Antibody reactivity was assessed using a dot blot which is a non-quantitative method that maintains the native conformation of beta Amyloid. beta Amyloid 1-40 and 1-42 peptides underwent the following aggregation conditions before being spotted onto a nitrocellulose membrane and detected using ab205340 :
Monomers : 0.3 mg of beta Amyloid peptide was dissolved in 30 μl 100 mM NaOH and incubated at room temperature for 10 minutes. It was then diluted with 970 μl of 1% SDS and boiled for five minutes.
Oligomers : 0.3 mg of beta Amyloid peptide was dissolved in 30 μl 100 mM NaOH and incubated at room temperature for 10 minutes. It was then diluted with 970 μl of 10 mM phosphate buffer pH 7.4 containing 0.02% sodium azide and incubated at room temperature for four days.
Fibrils : 0.3 mg of beta Amyloid peptide was dissolved in 1 ml 50% hexafluoroisopropanol (HFIP) with 0.02% sodium azide. It was then stirred constantly for nine days; the first seven with a cap on and the final two with the cap removed to allow evaporation of the HFIP. Fibrils were then sedimented at 20000 rpm in a microcentrifuge for 20 minutes and resuspended in 1 ml of PBS + 0.02% sodium azide.
- Dot
Unknown
Dot Blot - Anti-beta Amyloid antibody [mOC23] - Conformation-Specific (AB205340)
Negative control (secondary ab only) Dot blot analysis of beta Amyloid.
Lane 1 : beta Amyloid (Aβ) 1-40;
Lane 2 : beta Amyloid (Aβ) 1-42.
Goat Anti-Rabbit IgG (H+L) Peroxidase conjugated (ab97051) at 1/30000 was used as secondary antibody.
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 30 seconds.
関連する標識済み抗体及び組成の異なる製品 (1)
-
Anti-beta Amyloid antibody [mOC23] - BSA and Azide free
Reactivity data
製品の詳細
This antibody was developed as part of a collaboration between Abcam and Professor Charles Glabe, UC Irvine.
ab205340 (mOC23) recognizes an aggregation-dependent epitope of Aß that maps to a linear segment of Aß (residues 2-6, AEFRH) (Hatami et al 2014, PMID: 25281743). mOC23 stains a subset of plaques, but weakly stains the central core of cored plaques. mOC23 also stains misfolded or aggregated intraneuronal amyloid deposits (Hatami et al 2014, PMID: 25281743). Immunoreactivity on western blots is decreased by boiling the membrane.
For further information on the immunogen, please refer to Hatami et al 2014, PMID: 25281743 and Kayed et al. 2007, PMID: 17897471.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
In the context of neuronal function beta amyloid is significant yet contentious. It is believed to play a role in synaptic transmission and may partake in homeostatic regulation. However the true physiological role still remains not well defined. Beta amyloid often self-assembles into oligomers and further into beta amyloid plaques which are part of a larger complex that includes various cellular and molecular components. The plaques contribute to neural pathway disruptions and may interfere with synaptic connections.
Pathways
Beta amyloid integrates into important cellular processes such as the amyloidogenic and non-amyloidogenic pathways. The amyloidogenic pathway involves the sequential cleavage of APP by beta and gamma secretases leading to beta amyloid release which can aggregate. In contrast the non-amyloidogenic pathway mediated by alpha-secretase precludes beta amyloid formation. Proteins such as presenilin-1 and nicastrin are closely tied to beta amyloid formation due to their roles in the gamma-secretase complex.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (3)
Recent publications for all applications. Explore the full list and refine your search
Acta neuropathologica communications 10:182 PubMed36529803
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 296:100168 PubMed33298522
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 289:32131-43 PubMed25281743
2014
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com